Publications
By Year
Now showing items 861-880 of 5027 records
Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilization.
Yung-Chih Chen; Meaghan Smith; Ya-Lan Ying; Manousos Makridakis; Jonathan Noonan; Peter Kanellakis; Alin Rai; Agus Salim; Andrew Murphy; Alex Bobik; Antonia Vlahou; David W Greening; Karlheinz Peter
COMMUNICATIONS BIOLOGY - 13 Mar 2023
Atherosclerotic plaque rupture leading to myocardial infarction is a major global health burden. Applying the tandem stenosis (TS) mouse model, which distinctively exhibits the characteristics of human plaque instability/rupture, we use quantitative proteomics to understand and directly compare unstable and stable atherosclerosis. Our data highlight the disparate natures and define unique prote...
Haemodynamic and metabolic adaptations in coronary microvascular disease.
Samer Noaman; David M Kaye; Shane Nanayakkara; Anthony M Dart; Andy S C Yong; Martin Ng; Donna Vizi; Stephen J Duffy; Nicholas Cox; William Chan
HEART (BRITISH CARDIAC SOCIETY) - 17 Mar 2023
We aimed to evaluate the microcirculatory resistance (MR) and myocardial metabolic adaptations at rest and in response to increased cardiac workload in patients with suspected coronary microvascular dysfunction (CMD).Patients with objective ischaemia and/or myocardial injury and non-obstructive coronary artery disease underwent thermodilution-derived microcirculatory assessment and transcardiac...
The cost-effectiveness of coronary calcium score-guided statin therapy initiation for Australians with family histories of premature coronary artery disease.
Prasanna Venkataraman; Amanda L Neil; Geoffrey K Mitchell; Tony Stanton; Stephen Nicholls; Andrew M Tonkin; Gerald F Watts; Thomas H Marwick
THE MEDICAL JOURNAL OF AUSTRALIA - 20 Mar 2023
To compare the cost-effectiveness of coronary artery calcium (CAC) score-guided statin therapy criteria and American College of Cardiology/American Heart Association (ACC/AHA) guidelines (10-year pooled cohort equation [PCE] risk ≥ 7.5%) with selection according to Australian guidelines (5-year absolute cardiovascular disease risk [ACVDR] ≥ 10%), for people with family histories of premature co...
Brain activity changes associated with pain perception variability.
L Crawford; E Mills; N Meylakh; P M Macey; V G Macefield; L A Henderson
CEREBRAL CORTEX (NEW YORK, N.Y. : 1991) - 21 Mar 2023
Pain perception can be modulated by several factors. Phenomena like temporal summation leads to increased perceived pain, whereas behavioral conditioning can result in analgesic responses. Furthermore, during repeated, identical noxious stimuli, pain intensity can vary greatly in some individuals. Understanding these variations is important, given the increase in investigations that assume stab...
Trends in Exposure to Secondhand Smoke Among Adolescents in China From 2013-2014 to 2019: Two Repeated National Cross-sectional Surveys.
Chuanwei Ma; Yayang Huang; Sixuan Li; Min Zhao; Xinying Zeng; Xinbo Di; Costan G Magnussen; Bo Xi; Shiwei Liu
JMIR PUBLIC HEALTH AND SURVEILLANCE - 24 Mar 2023
It is well-known that secondhand smoke exposure in childhood or adolescence is positively associated with morbidity and mortality. However, less is known about the current status of and most recent trends in secondhand smoke exposure among adolescents in China.We aimed to assess recent changes in the prevalence of secondhand smoke exposure among adolescents in China using nationally representat...
Editorial: Insights in integrative physiology: 2021.
James T Pearson; Jacqueline K Phillips; Geoffrey A Head
FRONTIERS IN PHYSIOLOGY - 01 Jan 2023
Association of the American Heart Association's new "Life's Essential 8" with all-cause and cardiovascular disease-specific mortality: prospective cohort study.
Jiahong Sun; Yanzhi Li; Min Zhao; Xiao Yu; Cheng Zhang; Costan G Magnussen; Bo Xi
BMC MEDICINE - 29 Mar 2023
The American Heart Association recently updated its construct of what constitutes cardiovascular health (CVH), called Life's Essential 8. We examined the association of total and individual CVH metrics according to Life's Essential 8 with all-cause and cardiovascular disease (CVD)-specific mortality later in  life.Data were from the National Health and Nutrition Examination Survey (NHANES) 2005...
Incidence and severity of cytomegalovirus infection in seropositive heart transplant recipients.
Bradley J Gardiner; Jessica P Bailey; Mia A Percival; Beth A Morgan; Victoria M Warner; Sue J Lee; C Orla Morrissey; David M Kaye; Anton Y Peleg; Andrew J Taylor
CLINICAL TRANSPLANTATION - 29 Mar 2023
The frequency and significance of cytomegalovirus (CMV) infection in seropositive (R+) heart transplant recipients (HTR) is unclear, with preventative recommendations mostly extrapolated from other groups. We evaluated the incidence and severity of CMV infection in R+ HTR, to identify risk factors and describe outcomes.R+ HTR from 2010 to 2019 were included. Antiviral prophylaxis was not routin...
Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obese female mice.
Malathi S I Dona; Ian Hsu; Alex I Meuth; Scott M Brown; Chastidy A Bailey; Christian G Aragonez; Jacob J Russell; Crisdion Krstevski; Annayya R Aroor; Bysani Chandrasekar; Luis A Martinez-Lemus; Vincent G DeMarco; Laurel A Grisanti; Iris Z Jaffe; Alexander R Pinto; Shawn B Bender
BASIC RESEARCH IN CARDIOLOGY - 29 Mar 2023
Coronary microvascular dysfunction (CMD) is associated with cardiac dysfunction and predictive of cardiac mortality in obesity, especially in females. Clinical data further support that CMD associates with development of heart failure with preserved ejection fraction and that mineralocorticoid receptor (MR) antagonism may be more efficacious in obese female, versus male, HFpEF patients. Accordi...
Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A.
Simone Vink; Kalyana Bharati Akondi; Jean Jin; Kim Poth; Allan M Torres; Philip W Kuchel; Sandra L Burke; Geoffrey A Head; Paul F Alewood
MOLECULES (BASEL, SWITZERLAND) - 29 Mar 2023
Cardiovascular ailments are a major cause of mortality where over 1.3 billion people suffer from hypertension leading to heart-disease related deaths. Snake venoms possess a broad repertoire of natriuretic peptides with therapeutic potential for treating hypertension, congestive heart failure, and related cardiovascular disease. We now describe several taipan () natriuretic peptides TNPa-e whic...
The potential of integrating human and mouse discovery platforms to advance our understanding of cardiometabolic diseases.
Aaron W Jurrjens; Marcus M Seldin; Corey Giles; Peter J Meikle; Brian G Drew; Anna C Calkin
ELIFE - 31 Mar 2023
Cardiometabolic diseases encompass a range of interrelated conditions that arise from underlying metabolic perturbations precipitated by genetic, environmental, and lifestyle factors. While obesity, dyslipidaemia, smoking, and insulin resistance are major risk factors for cardiometabolic diseases, individuals still present in the absence of such traditional risk factors, making it difficult to ...
Dairy Product Consumption and Incident Prediabetes in the Australian Diabetes, Obesity, and Lifestyle Study With 12 Years of Follow-Up.
Isabel Al Slurink; Lei Chen; Dianna J Magliano; Nina Kupper; Tom Smeets; Sabita S Soedamah-Muthu
31 Mar 2023
Investigating modifiable risk factors for the early stages of the development of type 2 diabetes is essential for effective prevention. Some studies show protective associations between dairy and prediabetes; however, associations are heterogeneous by the type and fat content of dairy foods.To examine the relationship between the consumption of dairy, including different types of dairy products...
Sex differences among patients presenting to hospital with out-of-hospital cardiac arrest and shockable rhythm.
Felicia Cs Ho; Wayne C Zheng; Samer Noaman; Riley J Batchelor; Noah Wexler; Laura Hanson; Jason E Bloom; Omar Al-Mukhtar; Kawa Haji; Nicholas D'Elia; David Kaye; James Shaw; Yang Yang; Craig French; Dion Stub; Nicholas Cox; William Chan
EMERGENCY MEDICINE AUSTRALASIA : EMA - 01 Apr 2023
Sex differences in patients presenting with out-of-hospital cardiac arrest (OHCA) and shockable rhythm might be associated with disparities in clinical outcomes.We conducted a retrospective cohort study and compared characteristics and short-term outcomes between male and female adult patients who presented with OHCA and shockable rhythm at two large metropolitan health services in Melbourne, A...
Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification.
Clara Marquina; Jedidiah Morton; Ella Zomer; Stella Talic; Sean Lybrand; David Thomson; Danny Liew; Zanfina Ademi
VALUE IN HEALTH : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH - 01 Apr 2023
Attainment of low-density lipoprotein cholesterol (LDL-C) therapeutic goals in statin-treated patients remains suboptimal. We quantified the health economic impact of delayed lipid-lowering intensification from an Australian healthcare and societal perspective.A lifetime Markov cohort model (n = 1000) estimating the impact on coronary heart disease (CHD) of intensifying lipid-lowering treatment...
The future burden of oesophageal and stomach cancers attributable to modifiable behaviours in Australia: a pooled cohort study.
Maarit A Laaksonen; Siqi Li; Karen Canfell; Robert J MacInnis; Graham G Giles; Emily Banks; Julie E Byles; Dianna J Magliano; Jonathan E Shaw; Tiffany K Gill; Vasant Hirani; Robert G Cumming; Paul Mitchell; Michelle Bonello; ; Claire M Vajdic
BRITISH JOURNAL OF CANCER - 01 Apr 2023
We quantified the individual and joint contribution of contemporaneous causal behavioural exposures on the future burden of oesophageal and stomach cancers and their subtypes and assessed whether these burdens differ between population groups in Australia, as such estimates are currently lacking.We combined hazard ratios from seven pooled Australian cohorts (N = 367,058) linked to national canc...
The gut microbiome is a significant risk factor for future chronic lung disease.
Yang Liu; Shu Mei Teo; Guillaume Méric; Howard H F Tang; Qiyun Zhu; Jon G Sanders; Yoshiki Vázquez-Baeza; Karin Verspoor; Ville A Vartiainen; Pekka Jousilahti; Leo Lahti; Teemu Niiranen; Aki S Havulinna; Rob Knight; Veikko Salomaa; Michael Inouye
THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY - 01 Apr 2023
The gut-lung axis is generally recognized, but there are few large studies of the gut microbiome and incident respiratory disease in adults.We sought to investigate the association and predictive capacity of the gut microbiome for incident asthma and chronic obstructive pulmonary disease (COPD).Shallow metagenomic sequencing was performed for stool samples from a prospective, population-based c...
Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy.
Christopher R Defilippi; Wendimagegn G Alemayehu; Adriaan A Voors; David Kaye; Robert O Blaustein; Javed Butler; Justin A Ezekowitz; Adrian F Hernandez; Carolyn S P Lam; Lothar Roessig; Stephen Seliger; Palak Shah; Cynthia M Westerhout; Paul W Armstrong; Christopher M O'Connor;
JOURNAL OF CARDIAC FAILURE - 01 Apr 2023
Circulating biomarkers may be useful in understanding prognosis and treatment efficacy in heart failure with reduced ejection fraction. In the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial, vericiguat, a soluble guanylate cyclase stimulator, decreased the primary outcome of cardiovascular death or heart failure hospitalization in heart fa...
Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation.
Nisha Schwarz; Sanuja Fernando; Yung-Chih Chen; Thalia Salagaras; Sushma R Rao; Sanuri Liyanage; Anna E Williamson; Deborah Toledo-Flores; Catherine Dimasi; Timothy J Sargeant; Jim Manavis; Eleanor Eddy; Peter Kanellakis; Peter L Thompson; Joanne T M Tan; Marten F Snel; Christina A Bursill; Stephen J Nicholls; Karlheinz Peter; Peter J Psaltis
FASEB JOURNAL : OFFICIAL PUBLICATION OF THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY - 01 Apr 2023
Colchicine is a broad-acting anti-inflammatory agent that has attracted interest for repurposing in atherosclerotic cardiovascular disease. Here, we studied its ability at a human equivalent dose of 0.5 mg/day to modify plaque formation and composition in murine atherosclerosis and investigated its actions on macrophage responses to atherogenic stimuli in vitro. In atherosclerosis induced by hi...
SEARCHing for answers to youth-onset type 2 diabetes.
Jonathan E Shaw; Dianna J Magliano
THE LANCET. DIABETES & ENDOCRINOLOGY - 01 Apr 2023
Show more...